NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
Learn more: Fecal microbiota transplantation helps restore beneficial bacteria in cancer patients
The Latest on: Fecal microbiota transplantation
[google_news title=”” keyword=”fecal microbiota transplantation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Fecal microbiota transplantation
- Microbiota Therapeutics Could Become Strong Ally in IBD Treatmenton May 2, 2024 at 5:00 pm
Microbiota therapeutics, such as fecal microbiota transplantation (FMT), could offer more diverse, personalized treatment options for patients with inflammatory bowel disease (IBD), particularly for ...
- Cranberry extracts could boost microbiota and counter cardiometabolic diseaseson April 29, 2024 at 5:00 pm
Cranberry extracts appear to improve intestinal microbiota and help prevent chronic diseases such as diabetes and cardiovascular diseases. The study reported beneficial effects after only four days of ...
- Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptomson April 25, 2024 at 4:45 pm
For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when stool with healthy microorganisms is inserted into a sick patient’s digestive ...
- Researchers conclude fecal transplants can rid patients of resistant gut bacteriaon April 15, 2024 at 5:00 pm
Transferring fecal microbiota from healthy donors ... Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance ...
- Breakthrough: Poo transplant can slow Parkinson’s symptomson April 13, 2024 at 4:00 am
Parkinson's motor symptoms were improved in a clinical study in which early-stage patients were given fecal transplants.
- Examining the Potential of Fecal Transplantation as a Parkinson’s Disease Treatmenton April 8, 2024 at 10:05 pm
Fecal microbiota transplantation shows significant promise as a novel therapeutic option for early stage Parkinson’s disease patients. The potential for motor symptom improvement and the ...
- Stool Transplant Could Help Treat Parkinson's Diseaseon April 8, 2024 at 7:54 am
"Our study provides promising hints that fecal microbial transplant can be a valuable new treatment for Parkinson's disease," Roosmarijn Vandenbroucke, one of the study's co-authors, said in a ...
- Fecal Transplant Improves Symptoms in Early-Stage Parkinson'son April 7, 2024 at 3:28 pm
Fecal microbiota transplantation (FMT) may improve motor symptoms in early-stage Parkinson’s disease (PD). The findings could pave the way for new treatments for PD. The corresponding study was ...
- Belgian breakthrough: Stool transplant shows promise for improving symptoms of Parkinson's diseaseon April 7, 2024 at 6:22 am
Now, a groundbreaking clinical study conducted by researchers at Ghent University Hospital in Belgium has shown the potential of fecal microbiota transplantation (FMT) to improve symptoms in ...
via Bing News